KINASE INHIBITORS
A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors
Using data from clinical trials, meta-analyses, case reports, and reviews, this article discusses the 52 FDA-approved small-molecule kinase inhibitors in the treatment of cancer and their known associated cardiotoxicities.
Frontiers in Pharmacology
